Rapport Therapeutics Inc. (RAPP) Live Share Price, Invest From India

Rapport Therapeutics Inc. Stock Performance

as on June 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$36.46
Day's Price Range
$38.12
$37.34
2.36%
Downside
2.09%
Upside
52 Week's Low
52 Week's High
$10.51
52-Week Price Range
$42.27
$37.34
71.87%
Downside
13.20%
Upside

Rapport Therapeutics Inc. share price movements today

Previous Close: $36.87
Open: $37.75
Volume: 461.1K
Day's Low - High: $36.46 - $38.12
52 Week Low - High: $10.51 - $42.27

Rapport Therapeutics Inc. Historical Returns

1 Month Return: + 8.64 %
3 Month Return: + 35.98 %
1 Year Return: + 238.53 %
3 Year Return: 0 %
5 Year Return: 0 %

Rapport Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Rapport Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-3.4717

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-28.33%

Rapport Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rapport Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Rapport Therapeutics Inc.	NA	$1.8B	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Rapport Therapeutics Inc. Stock including INR - Dollar returns

The Rapport Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Rapport Therapeutics Inc. investment value today

Current value as on today

₹3,67,650

Returns

₹2,67,650

(+267.65%)

Returns from Rapport Therapeutics Inc. Stock

₹2,38,531 (+238.53%)

Dollar Impact

₹29,118 (+29.12%)

Indian Investors' Interest in Rapport Therapeutics Inc. Stock

Search interest for Rapport Therapeutics Inc. Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 21, 2026 to June 20, 2026

Change:-30% versus previous 30 day period

Rapport Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	0	-	-	-	-	20
Gross Profit	0	0	0	0	0	0	0	0	0	19
Operating Income	-14	-17	-20	-21	-23	-27	-29	-29	-38	-24
EBITDA	-13	-16	-20	-21	-23	-26	-29	-26	-38	-23
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-13	-22	-18	-17	-19	-24	-26	-26	-33	-19
Income Tax Expense	0	-	-	-	-	-	-	-	-	-
Net Income	-13	-22	-18	-17	-19	-24	-26	-26	-33	-19
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-2775.00%	0.00%	0.00%	0.00%	0.00%	-99.29%

Rapport Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-
Gross Profit	0	0	-1
Operating Income	-36	-83	-125
EBITDA	-34	-77	-124
Interest Expense	-	-	-
Depreciation	0	0	1
Income Before Tax	-34	-78	-111
Income Tax Expense	0	-	-
Net Income	-34	-78	-111
Net Profit Margin	0.00%	0.00%	0.00%

Rapport Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-22	-18	-17	-19	-24	-26	-26	-33	-19
Operating Cash Flow	-17	-16	-16	-14	-20	-25	-17	-24	-13
Investing Cash Flow	-41	-107	-53	31	21	22	-56	-174	37
Financing Cash Flow	63	159	-1	0	0	0	270	0	0
Change in Cash	4	35	-70	17	0	-2	196	-198	25

Rapport Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Net Income	-34	-78	-111
Operating Cash Flow	-27	-64	-87
Investing Cash Flow	-78	-170	-187
Financing Cash Flow	145	221	270
Change in Cash	39	-13	-4

Global Institutional Holdings in Rapport Therapeutics Inc.

Funds	Holdings
TRV GP V, LLC	14.92%
ARCH VENTURE CORP	7.8%
Sofinnova Ventures	3.98%
Vanguard Group Inc	3.8%
Baker Bros Advisors LP	3.23%

See all

Insights on Rapport Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, RAPP stock has moved up by 241.9%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, RAPP has outperformed top 5 stocks with highest market-cap in its industry

About Rapport Therapeutics Inc.

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. The company's lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. It also develops nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and migraine; and a9a10 nAChR for the treatment of hearing/vestibular disorders. The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts.

Organisation	Rapport Therapeutics Inc.
Headquarters	99 High Street, Boston, MA, United States, 02110
Industry	Biotechnology
CEO	Mr. Abraham N. Ceesay M.B.A.
E-voting on shares	Click here to vote

Key Management of Rapport Therapeutics Inc.

Name	Title
Ms. Karina Chmielewski	Chief Information Officer & Head of Operations
Dr. Steven M. Paul M.D.	Founder & Independent Chairman
Mr. Troy A. Ignelzi	Chief Financial Officer
Dr. David Bredt M.D., Ph.D.	Founder & Chief Scientific Officer
Ms. Cheryl Gault	Chief Operating Officer
Ms. Julie DiCarlo	Head of Communications & Investor Relations
Ms. Kathleen A. Wilkinson	Chief People Officer
Mr. Swamy Yeleswaram Ph.D.	Chief Development Officer
Mr. Abraham N. Ceesay M.B.A.	CEO, President, Treasurer & Director
Dr. Jeffrey Sevigny M.D.	Chief Medical Officer

FAQs

What is Rapport Therapeutics Inc. share price today?

Rapport Therapeutics Inc. share price today is $37.34 as on June 19, 2026 at 8:45 am IST at the close of the market. Rapport Therapeutics Inc. share today touched a day high of $38.12 and a low of $36.46.

What is the 52 week high and 52 week low for Rapport Therapeutics Inc. share?

Rapport Therapeutics Inc. share touched a 52 week high of $42.27 on September 8, 2025 and a 52 week low of $10.51 on June 23, 2025. Rapport Therapeutics Inc. stock price today i.e. June 19, 2026 at 8:45 am IST is closed at $37.34,which is 11.66% down from its 52 week high and 255.45% up from its 52 week low.

What is Rapport Therapeutics Inc.'s market capitalisation today?

Rapport Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:45 am IST.

How to invest in Rapport Therapeutics Inc. Stock (RAPP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Rapport Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rapport Therapeutics Inc. Shares that will get you 0.0402 shares as per Rapport Therapeutics Inc. share price of $37.34 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Rapport Therapeutics Inc. Stock (RAPP) from India?

Indian investors can start investing in Rapport Therapeutics Inc. (RAPP) shares with as little as ₹94.31 or $1 (as of June 20, 2026 at 8:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Rapport Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 20, 2026 at 8:38 pm IST). Based on Rapport Therapeutics Inc. share’s latest price of $37.34 as on June 19, 2026 at 8:45 am IST, you will get 0.2678 shares of Rapport Therapeutics Inc.. Learn more about fractional shares .